This app is for sale. Asking price: $23,860
2.2x revenue
339 buyers have viewed this
2 offers made
Shotwise app icon

Shotwise

Wegovy, Ozempic, Mounjaro

Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.

Worldwide Release Date: January 9, 2025

Verified withRevenueCatFor Sale
#158 MRR
#209 Revenue
#51 in Health & Fitness
Transparency: 10/10

Star Ratings(129 ratings | avg ★ 4.6)

App Store (129 ratings)

us

4.7

106 ratings

gb

4.5

14 ratings

ca

5.0

4 ratings

nl

2.5

2 ratings

fr

5.0

1 rating

de

3.0

1 rating

br

5.0

1 rating

Total Downloads (Android)

100+

Last 28 days

Revenue

$898

AR

$10,776

MRR

$1,193

ARR

$14,316

Cash Flow Index

0.8x

Active Subscriptions

756

Active Trials

2

ARPAS

$1.18

Paid Subscriber Share (snapshot)

99.7%

Active Customers

636

New Customers

171

Subscription Penetration

118.9%

ARPU

$1.41

RPD

$1.41

ARPPU

$1.58

LTV

$16

MRR Growth (28d)

-2.2%

Subscriber Growth (28d)

-4.1%

All data is verified through RevenueCat. Last updated: Aug 12, 2026, 05:31:05 AM UTC.

App Screenshots

Shotwise screenshot 1
Shotwise screenshot 2
Shotwise screenshot 3
Shotwise screenshot 4
Shotwise screenshot 5

In-App Pricing

ShotWise Pro Annual$24.99
ShotWise Pro Annual$9.99
Shotwise Pro Annual$4.99

Tech Stack

Frontend
ExpoExpo

About This Listing

A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.

Asking Price

$23,860

Sale Details

Business Operations Started

Jan 2025

Assets Included in Sale

Social media accounts

Source Code Included

Yes

Post-Sales Support

Yes, seller will provide support
Privacy Policy|Terms of Service